MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹300 Cr | ₹5.20 Cr | ₹144 Cr | ₹66 Cr | ₹47 Cr |
What is the latest Cash Flow from Financing Activities ratio of MOREPEN LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹5.20 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹66 Cr |
| Mar2021 | ₹47 Cr |
How is Cash Flow from Financing Activities of MOREPEN LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹300 Cr | 5,661.50 | |
| Mar2024 | ₹5.20 Cr | -96.37 | |
| Mar2023 | ₹144 Cr | 116.39 | |
| Mar2022 | ₹66 Cr | 40.32 | |
| Mar2021 | ₹47 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,919.2 Cr | -12.4% | 6.2% | -9.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -12.4% |
6.2% |
-9.8% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses